Pharmacy & Therapeutics - January 2009 - (Page 45) CONTINUING EDUCATION CREDIT of papulopustular rosacea: Results of a randomized trial. Arch Dermatol 2003;139(11):1444–1450. Colon LE, Johnson LA, Gottschalk RW. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. Cutis 2007;79:317–321. Madsen JT, Thormann J, Kerre S, et al. Allergic contact dermatitis to topical metronidazole: Three cases. Contact Dermatitis 2007;56:364–366. Weissenbacher S, Merkl J, Hildebrandt B, et al. Pimecrolimus cream 1% for papulopustular rosacea: A randomized vehiclecontrolled double-blind trial. Br J Dermatol 2007;156:728–732. Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol 2007;21:484–490. Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1adrenergic receptor agonist, oxymetazoline. Arch Dermatol 2007; 143(11):1369–1371. Wozniacka A, Wierczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: A pilot study. Clin Exp Dermatol 2005;30(6): 632–635. Callender VD. Acne in ethnic skin: Special considerations for therapy. Dermatol Ther 2004;17(2):184–195. Theobald K, Bradshaw M, Leyden J. Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum antiinflammatory efficacy in rosacea. Skinmed 2007;6:221–226. Low-dose doxycycline (Oracea) for rosacea. Med Lett Drugs Ther 2007;49(1252):5–6. Berman B, Perez OA, Zell D. Update on rosacea and anti-inflammatory-dose doxycycline. Drugs Today (Barc) 2007;43:27–34. Fernandez-Obregon A, Patton DL. The role of Chlamydia pneumoniae in the etiology of acne rosacea: Response to the use of oral azithromycin. Cutis 2007;79:163–167. Bakar O, Demircay Z, Yuksel M, et al. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 2007; 32:197–200. Rebora A. The management of rosacea. Am J Clin Dermatol 2002;3:489–496. Fowler JF. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, USP monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol 2007;6(6);641–645. Larson AA, Goldman MP. Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser. J Drugs Dermatol 2007; 6:843–845. Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 2007; 33:449–454. Blount BW, Pelletier AL. Rosacea: A common, yet commonly overlooked, condition. Am Fam Physician 2002;66(3):435–440. Laqueize S, Czernieleski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatol Treat 2007;18(3):158–162. Wu JJ, Weistein GD, Kricorian GJ, et al. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol 2007;32(6):693–695. Wu J. Treatment of rosacea with herbal ingredients. J Drugs Dermatol 2006;5(1):29–32. Yu TG, Zheng YZ, Zhu JT, Guo W. Effect of treatment of rosacea in females by Chibixiao recipe in combination with minocycline and spironolactone. Chin J Integr Med 2006;12:277–280. Millikan L. Recognizing rosacea: Could you be misdiagnosing this common skin disorder? Postgrad Med 1999;105(2). Smith K, Leyden JJ. Safety of doxycycline and minocycline: A systematic review. Clin Ther 2005;27(9):1329–1342. Baxi S. OTC products for the treatment of acne. US Pharmacist 2007;32(7):13–17. Pray JJ, Pray WS. Teenagers and acne: The role of the pharmacist. US Pharmacist 2003;28(6). Rochester CD. Drug interactions in dermatology: Are they just skin deep? US Pharmacist 2007;32(4):HS29–HS39. Stone DU, Chodosh J. Ocular rosacea: An update on pathogenesis and therapy. Curr Opin Ophthalmol 2004;15:499–502. Kheirkhah A, Casas V, Li W, et al. Corneal manifestations of ocular Demodex infestation. Am J Ophthalmol 2007;143:743–749. Bormann G, Gaber G, Fischer M, Marsch WC. Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 2001;15:465–467. Aroni K, Tsagroni E, Lazaris AC, et al. Rosacea: A clinicopathological approach. Dermatology 2004;209:177–182. I 19. 20. 21. 22. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. Conflict of Interest (COI) Statement The authors have no relationships to disclose. The article contains discussion of off-label use. The content of this article has been reviewed under Jefferson’s Continuing Medical Education COI policy. 33. 34. Vol. 34 No. 1 • January 2009 • P&T® 45
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.